Chongqing Pharma Research Institute 483, May 2016

Chongqing Pharma Research Institute 483, May 2016

Peter Baker FDA, Marijo Kambere FDA$119.00

FDA investigators audited the Chongqing Pharma Research Institute facility in Zhongqing, China and issued inspectional observations (via FDA 483) on 19 May 2016.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 19 May 2016
  • Location: Zhongqing, China